Literature DB >> 7473982

Intracranial hypertension and adult respiratory distress syndrome: usefulness of tracheal gas insufflation.

B Levy1, P E Bollaert, L Nace, A Larcan.   

Abstract

The management of increased intracranial pressure (ICP) in patients with an associated acute lung injury is difficult. High levels of PaCO2 as tolerated for permissive hypercapnia are deleterious for cerebral circulation. In such circumstances, tracheal gas insufflation (TGI), which was recently proposed to reduce PaCO2, may be of benefit. We report the cases of two patients with severe adult respiratory distress syndrome and head trauma complicated with elevated ICP. The introduction of TGI decreased PaCO2 by 17 and 26%, decreased ICP, and increased calculated cerebral perfusion pressure. We conclude that TGI could be added to a pressure-targeted strategy of ventilatory management when severe adult respiratory distress syndrome was associated to an intracranial hypertension.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7473982     DOI: 10.1097/00005373-199510000-00039

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  3 in total

1.  Effects of CO2 insufflation on cerebrum during endoscopic thyroidectomy in a porcine model.

Authors:  Wenbin Yu; Feng Li; Zhigang Wang; Xiaoliang Qi; Bo Li; Guangyong Zhang; Xiaoguang Hao; Sanyuan Hu
Journal:  Surg Endosc       Date:  2010-10-26       Impact factor: 4.584

2.  Effects of expiratory tracheal gas insufflation in patients with severe head trauma and acute lung injury.

Authors:  Melcior Martínez-Pérez; Francesca Bernabé; Rocío Peña; Rafael Fernández; Avi Nahum; Lluís Blanch
Journal:  Intensive Care Med       Date:  2004-09-14       Impact factor: 17.440

3.  Optimal carbon dioxide insufflation pressure during robot-assisted thyroidectomy in patients with various benign and malignant thyroid diseases.

Authors:  Hoon Yub Kim; Yoon Ji Choi; Hae-Na Yu; Seung Zhoo Yoon
Journal:  World J Surg Oncol       Date:  2012-09-27       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.